Innovative Cellular Therapeutics
Business Services · Maryland, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1405 Research Blvd Ste 210, Rockville, M...Phone Number
(240) 690-9110Website
www.ictbio.comRevenue
$6.9 MillionIndustry
About Innovative Cellular Therapeutics
Innovative Cellular Therapeutics (ICT) is a clinical-stage biotechnology company focused on developing next-generation CAR-T therapies to transform cancer treatment globally. Their proprietary platforms, CoupledCAR and INSTACAR, support the research and development of cellular immunotherapies for solid tumors, with a leading product, GCC19CART, targeting relapsed/refractory metastatic colorectal cancer. ICT is expanding its CAR-T candidate portfolio to address various solid tumors and employs the ARMORED CAR platform to enhance therapy effectiveness. The company aims to provide innovative solutions for patients suffering from cancer through advanced immunotherapy strategies.Explore more
Innovative Cellular Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Innovative Cellular Therapeutics
Compare insights from companies similar to Innovative Cellular Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Innovative Cellular Thera...
$6.9M
51-200
Private
$28.6M
2009
LX
Larry XiaoFounder & Chairman & CEO, CSO
Innovative Cellular Therapeutics Tech Stack
A closer look at the technologies used by Innovative Cellular Therapeutics
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Innovative Cellular Therapeutics
Sign Up For FreeTo access detailed company insights
Innovative Cellular Therapeutics (ICT) is a clinical-stage biotechnology company focused on developing next-generation CAR-T therapies to transform cancer treatment globally. Their proprietary platforms, CoupledCAR and INSTACAR, support the research and development of cellular immunotherapies for solid tumors, with a leading product, GCC19CART, tar... Read More
